Hollings C. Renton
Lead Independent DirectorMr. Hollings C. Renton, III., M.B.A., served as an Independent Director since March 9, 2010 to June 2020 & Chairman since March 09, 2010 at Portola Pharmaceuticals, Inc. and served as its Lead Director since March 9, 2010. He served as the Chairman of Onyx Pharmaceuticals, Inc., from June 2000 to March 31, 2008. Mr. Renton served as Chief Executive Officer and President at Onyx Pharmaceuticals, Inc. from March 1993 to March 31, 2008 and served as its Principal Financial Officer until April 12, 2006. Mr. Renton has experience building successful biotechnology companies, commercializing blockbuster products and forging industry-leading partnerships. Mr. Renton served as the President and Chief Operating Officer of Chiron Corporation from December 1991 to December 1993. He joined Cetus Corporation in 1981 and served as its Chief Financial Officer from 1983 to 1987. He served as the President of Cetus Corporation from August 1990 to December 1991 and Chief Operating Officer from 1987 to August 1990. During his tenure at Chiron Corporation and Onyx Pharmaceuticals, Inc. Mr. Renton demonstrated outstanding leadership qualities as well as a deep understanding of the opportunities and challenges faced by evolving pharmaceutical companies. He served as the Chairman of Affymax, Inc. from December 2009 to June 6, 2013. He has been an Independent Director of AnaptysBio, Inc. since June 30, 2015 and its Lead Independent Director. He had been an Independent Director of Zymeworks Inc. since February 3, 2017 until December 10, 2024. Mr. Renton served as a Director at Cepheid, Inc. since March 2000 until November 4, 2016. He served as a Director of Affymax, Inc. from June 10, 2009 to November 2014 and as its Lead Director since December 1, 2009. He served as Director of Kythera Biopharmaceuticals, Inc from January 05, 2015 to October 1, 2015. Mr. Renton served as a Director of Biotechnology Innovation Organization. He served as an Independent Director of Rigel Pharmaceuticals, Inc. from January 20, 2004 to March 30, 2014. He served as a Director of Onyx Pharmaceuticals, Inc., from April 1992 to March 31, 2008. He served as a Director of Sangstat Medical Corporation since May 2002. He is a Director of Special Olympics Northern California. Mr. Renton holds an MBA degree from the University of Michigan and a BS degree in Mathematics from Colorado State University.
Positions
- Company NameAnaptysBio, Inc.Stock CodeANABPositionLead Independent DirectorColleagues
